ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ETNB 89bio Inc

9.22
0.36 (4.06%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
89bio Inc ETNB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.36 4.06% 9.22 23:00:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.19 8.90 9.35 9.22 8.86
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/3/202416:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..
01/3/202416:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:10EDGAR2Form 8-K - Current report
23/2/202419:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202410:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202315:43EDGAR2Form 8-K - Current report
08/12/202305:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202315:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202315:02EDGAR2Form 8-K - Current report
04/12/202306:01EDGAR2Form 8-K - Current report
27/11/202307:01EDGAR2Form 8-K - Current report
14/11/202315:30EDGAR2Form 8-K - Current report
09/11/202314:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202319:41EDGAR2Form 8-K - Current report
21/9/202308:07DJN89bio Gets FDA Breakthrough Designation for Pegozafermin in..
12/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:27EDGAR2Form 8-K - Current report
09/8/202315:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:12EDGAR2Form 8-K - Current report
05/7/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock